Russell P Tracy Selected Research

procollagen Type III-N-terminal peptide (PIIP)

11/2018	Collagen biomarkers predict new onset of hypertension in normotensive participants: the Multi-Ethnic Study of Atherosclerosis.
10/2018	Collagen Biomarkers and Incidence of New Onset of Atrial Fibrillation in Subjects With No Overt Cardiovascular Disease at Baseline: The Multi-Ethnic Study of Atherosclerosis.
7/2017	Collagen Turnover Markers in Relation to Future Cardiovascular and Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis.
4/2015	Fibrosis-related biomarkers and large and small vessel disease: the Cardiovascular Health Study.
8/2014	Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study.
6/2014	Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health study.
11/2011	The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Russell P Tracy Research Topics

Disease

97	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2002
86	Inflammation (Inflammations) 01/2022 - 01/2002
58	Atherosclerosis 01/2022 - 04/2002
32	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2002
25	Heart Failure 01/2022 - 09/2003
23	Insulin Resistance 06/2022 - 02/2002
23	Hypertension (High Blood Pressure) 01/2019 - 01/2002
22	Stroke (Strokes) 01/2022 - 01/2002
21	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2002
17	Obesity 01/2021 - 01/2003
15	Myocardial Infarction 01/2022 - 05/2002
11	Diabetes Mellitus 01/2017 - 11/2002
10	Acquired Immunodeficiency Syndrome (AIDS) 06/2021 - 07/2010
10	Fibrosis (Cirrhosis) 01/2021 - 07/2009
9	Atrial Fibrillation 11/2021 - 12/2003
9	Ischemic Stroke 01/2018 - 10/2004
8	HIV Infections (HIV Infection) 01/2018 - 01/2012
7	Thrombosis (Thrombus) 12/2021 - 02/2003
7	Neoplasms (Cancer) 01/2021 - 12/2002
7	Weight Loss (Weight Reduction) 08/2015 - 11/2010
6	Dementia (Dementias) 01/2022 - 11/2008
6	Infections 12/2021 - 12/2012
6	Vascular Diseases (Vascular Disease) 06/2021 - 03/2002
6	Sleep Apnea Syndromes (Sleep Apnea) 01/2021 - 04/2005
6	Frailty 12/2020 - 11/2002
6	Kidney Diseases (Kidney Disease) 10/2016 - 08/2006
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2016 - 04/2004
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 02/2015
5	Cognitive Dysfunction 01/2022 - 01/2017
5	Apnea 01/2021 - 04/2005
5	Dyslipidemias (Dyslipidemia) 01/2021 - 09/2007
5	Albuminuria 01/2019 - 10/2003
5	Pulmonary Arterial Hypertension 01/2016 - 06/2011
5	Coronary Artery Disease (Coronary Atherosclerosis) 09/2013 - 04/2002
4	Heart Diseases (Heart Disease) 01/2022 - 10/2005
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 04/2012
4	Obstructive Sleep Apnea 01/2022 - 07/2007
4	Peripheral Arterial Disease 01/2019 - 09/2003
4	Overweight 08/2015 - 07/2011
4	Venous Thromboembolism 06/2015 - 12/2002
3	Emphysema 01/2022 - 02/2015
3	Atrophy 01/2022 - 01/2015
3	Fatty Liver 12/2020 - 09/2015
3	Hemorrhage 02/2020 - 04/2003
3	Necrosis 01/2020 - 03/2015
3	Carotid Stenosis (Carotid Artery Stenosis) 01/2019 - 04/2003
3	Viremia 01/2018 - 08/2013

Drug/Important Bio-Agent (IBA)

64	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2003
64	C-Reactive ProteinIBA 10/2021 - 02/2002
34	Interleukin-6 (Interleukin 6)IBA 10/2021 - 12/2002
32	Fibrinogen (Factor I)FDA Link 10/2021 - 02/2002
21	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2002
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
15	fibrin fragment D (D-dimer)IBA 02/2020 - 01/2003
13	LipidsIBA 12/2021 - 04/2002
13	oxidized low density lipoproteinIBA 06/2021 - 08/2003
12	Lipopolysaccharide ReceptorsIBA 01/2021 - 01/2013
11	Plasminogen Activator Inhibitor 1IBA 01/2020 - 04/2002
11	CalciumIBA 12/2019 - 11/2002
10	CytokinesIBA 01/2022 - 02/2002
10	CholesterolIBA 01/2021 - 01/2004
10	Triglycerides (Triacylglycerol)IBA 01/2021 - 05/2003
10	AdiponectinIBA 01/2020 - 01/2012
10	Insulin (Novolin)FDA Link 01/2018 - 01/2002
9	HDL CholesterolIBA 01/2022 - 09/2006
9	CreatinineIBA 01/2021 - 09/2002
8	Cystatin CIBA 01/2017 - 12/2005
8	LDL CholesterolIBA 01/2016 - 01/2002
8	Plasminogen Activators (Plasminogen Activator)IBA 11/2014 - 04/2002
7	procollagen Type III-N-terminal peptide (PIIP)IBA 11/2018 - 11/2011
6	Fatty Acids (Saturated Fatty Acids)IBA 11/2021 - 02/2003
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 03/2003
6	InterleukinsIBA 09/2017 - 12/2002
6	Hemostatics (Antihemorrhagics)IBA 12/2008 - 03/2002
5	Nonesterified Fatty Acids (NEFA)IBA 06/2022 - 04/2012
5	Apolipoproteins E (ApoE)IBA 01/2022 - 08/2007
5	Biological ProductsIBA 01/2020 - 11/2002
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2019 - 06/2011
5	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2019 - 06/2014
5	AlbuminsIBA 01/2019 - 02/2002
5	RNA (Ribonucleic Acid)IBA 01/2019 - 04/2013
5	CollagenIBA 11/2018 - 07/2009
5	pro-brain natriuretic peptide (1-76)IBA 10/2016 - 07/2009
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015 - 02/2002
5	Factor VIII (Coagulation Factor VIII)IBA 11/2014 - 12/2002
4	Amyloid (Amyloid Fibrils)IBA 01/2020 - 02/2007
4	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2020 - 09/2003
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018 - 02/2003
4	Peroxidase (Myeloperoxidase)IBA 07/2016 - 05/2009
4	Hormones (Hormone)IBA 09/2015 - 01/2006
4	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2015 - 11/2012
4	Collagen Type III (Type III Collagen)IBA 04/2015 - 07/2009
3	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2018
3	Antihypertensive Agents (Antihypertensives)IBA 11/2018 - 04/2003
3	Indicators and Reagents (Reagents)IBA 09/2017 - 02/2003
3	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2017 - 03/2013
3	Peptides (Polypeptides)IBA 01/2017 - 07/2009

Therapy/Procedure

25	Therapeutics 01/2022 - 04/2002
7	Art Therapy 06/2021 - 01/2012
4	Precision Medicine 01/2022 - 10/2020